Form 4: Sabra Health Care REIT Executive Awarded Stock Units

Sabra Health Care REIT's Executive VP & CAO, Jessica Flores, received a grant of 9,958 stock units under the company's performance incentive plan.

Summary

• Jessica Flores, Executive VP & CAO of Sabra Health Care REIT, Inc. (SBRA), was granted 9,958 common stock units.
• The transaction date for this grant was December 31, 2025, with a price of $0 per unit.
• These stock units will vest at a rate of 25% on December 31, 2026, December 31, 2027, December 31, 2028, and December 31, 2029.
• Vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock during the 2030 calendar year, with potential for earlier payment upon separation from service, death, disability, or change of control.
• Following this transaction, Jessica Flores beneficially owns 83,607 securities, which includes 34,030 stock units that will settle into common stock.

Sentiment

Score: 6

Explanation: The filing reports a routine equity grant to an executive, which is generally seen as a positive for aligning management interests with shareholders, though it doesn't reflect company performance or significant new strategic direction.

Positives

• The grant of 9,958 stock units aligns the executive's long-term interests with those of shareholders, promoting sustained performance.
• Equity-based compensation is a standard practice to attract and retain key talent within the industry.

Negatives

• The stock units have a long vesting schedule, with full vesting not occurring until December 31, 2029, and payment in shares in 2030, meaning no immediate liquidity for the executive.
• The grant price of $0 indicates it is a compensatory award, not a purchase, which could be perceived as dilutive to existing shareholders upon conversion.

Risks

• The value of the stock units is subject to the future market performance of Sabra Health Care REIT's common stock.
• The executive risks forfeiture of unvested units if employment terminates prior to the vesting dates, except under specific conditions like death, disability, or change of control.

Future Outlook

The grant of performance-based stock units indicates a long-term incentive structure for the executive, with the payout tied to future performance and continued service through 2029 and share delivery in 2030.

Industry Context

Equity grants to executive officers are a common component of compensation packages across the REIT sector and broader public companies, designed to incentivize long-term performance and align management interests with shareholder value creation.

Comparison to Industry Standards

• The structure of this equity grant, with multi-year vesting and a performance incentive plan, is consistent with typical executive compensation practices observed in the U.S. REIT industry.
• Similar long-term incentive plans are utilized by comparable healthcare REITs to retain key executives and foster commitment to strategic objectives.

Stakeholder Impact

• Shareholders: Potential for minor dilution upon the eventual issuance of shares from the vested units, but also benefits from enhanced alignment of executive incentives with long-term company performance.
• Employees (Executive): Jessica Flores receives a significant long-term incentive, tying her financial success to the company's stock performance and ensuring retention through the vesting period.

Next Steps

• The stock units will vest incrementally on December 31, 2026, 2027, 2028, and 2029.
• Vested units are scheduled for payment in shares of common stock during the 2030 calendar year.

Key Dates

Keywords

Sabra Health Care REIT, SBRA, Form 4, Stock Grant, Executive Compensation, Equity Award, Jessica Flores, Insider Transaction